In diabetic nephropathy, insufficient HIF-1α activation was proposed as a factor of progression [47], and the efficiency of HIF-PHIs in renal anaemia treatment also points towards suboptimal activation [13]. This evidence concerns the gene HIF1A and diabetic kidney disease.